Casi PharmaceuticalsCASIF
13F holders, Q2 2024 (June 30)23holders +3
7new positions
4sold out
1famous investor
$5.50avg. 13F price*
At the end of Q2 2024, 23 institutions reported holding Casi Pharmaceuticals Inc. (CASIF) in their 13F filings, up 3 from Q1 2024. 7 opened new positions and 4 sold out. The largest holders were Venrock Adviser, LLC ($614K), Wellington Shields Capital Management, LLC ($491K) and Wellington Shields & Co., LLC ($237K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Casi Pharmaceuticals Inc.
- CUSIP
- G1933S101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $761K |
| Exits | 4 | $3K |
All 13F filers, Q1 2024 → Q2 2024: 142,687 shares bought and 42,519 shares sold, net +100,168 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 23 holders
| Venrock Adviser, LLC | 0.04% | New | 111,686 | $614K |
| Wellington Shields Capital Management, LLC | 0.09% | Reduce -3.3% | 89,217 | $491K |
| Wellington Shields & Co., LLC | 0.08% | No change | 43,091 | $237K |
| Renaissance Technologies | 0.00% | Add +10.9% | 40,800 | $224K |
| Geode Capital Management, LLC | 0.00% | No change | 22,221 | $122K |
| Howland Capital Management LLC | 0.00% | Reduce -62.7% | 15,072 | $83K |
| UBS Group AG | 0.00% | New | 11,321 | $62K |
| ADAR1 Capital Management, LLC | 0.01% | New | 8,240 | $45K |
| Royal Bank of Canada | 0.00% | New | 6,900 | $38K |
| Morgan Stanley | 0.00% | Add +0.2% | 1,440 | $8K |
| Simplex Trading, LLC | 0.00% | Add +67.3% | 1,042 | $5K |
| Wells Fargo & Company | 0.00% | Reduce -95.8% | 506 | $3K |
| BlackRock Inc. | 0.00% | No change | 296 | $2K |
| West Paces Advisors Inc. | 0.00% | No change | 100 | $550 |
| Qube Research & Technologies Ltd | 0.00% | New | 100 | $550 |
| Bank of America Corp. | 0.00% | No change | 53 | $292 |
| JPMorgan Chase & Co. | 0.00% | No change | 25 | $138 |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 13 | $72 |
| Colonial Trust Co / SC | 0.00% | No change | 11 | $61 |
| Trust Co. of Vermont | 0.00% | New | 10 | $55 |
| Kozak & Associates, Inc. | 0.00% | No change | 10 | $53 |
| Osaic Holdings, Inc. | 0.00% | New | 8 | $44 |
| Catalyst Funds Management Pty Ltd | 0.00% | Reduce -99.6% | 8 | $44 |
"% of holder's portfolio" is CASIF's weight in each manager's 13F, not the share of Casi Pharmaceuticals Inc. the manager owns.